Skip to main content
. 2019 Feb 22;3(3):217–223. doi: 10.1002/jgh3.12140

Figure 1.

Figure 1

(a) Mayo scores before and 12 weeks after the start of tacrolimus therapy in the group without previous tumor necrosis factor‐α (TNF‐α) inhibitor therapy. (b) Mayo scores before and 12 weeks after the start of tacrolimus therapy in the group with previous TNF‐α inhibitor therapy.